Figure 1. Kaplan-Meier Curve of IDFS
The IDFS at 5 years was 89.5%. The median was not reached.

From: Clinical Information and Prognosis of High-risk Luminal Breast Cancer Subjects Eligible for the MonarhE Study

Figure 2. Kaplan-Meier Curve of DRFS
The DRFS at 5 years was 89.0%. The median was not reached.

From: Clinical Information and Prognosis of High-risk Luminal Breast Cancer Subjects Eligible for the MonarhE Study

Figure 3. Kaplan-Meier Curve of OS
The OS at 5 years was 95.0%. The median was not reached.

From: Clinical Information and Prognosis of High-risk Luminal Breast Cancer Subjects Eligible for the MonarhE Study

Figure 4. Comparison of four or more lymph node metastases and the following IDFS
The Kaplan-Meier curve of IDFS divided by number of lymph node metastases (p = 0.35, HR: 1.42 [95% CI: 0.68-2.96]). (p = 0.225, HR: 1.57 [95% CI: 0.75 3.25]).

From: Clinical Information and Prognosis of High-risk Luminal Breast Cancer Subjects Eligible for the MonarhE Study

Figure 5. Comparison of premenopausal and postmenopausal the following IDFS
The Kaplan-Meier curve of IDFS divided by menopause is shown. (p = 0.35, HR: 1.42 [95% CI: 0.68-2.96]).

From: Clinical Information and Prognosis of High-risk Luminal Breast Cancer Subjects Eligible for the MonarhE Study

PAGE TOP